Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)21

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)4

Views

Views
August 20241
September 20240
October 20241
November 20240
December 20241
January 20251
February 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Canada1
United Kingdom1
 

Top cities views

Views
Buffalo1
Toronto1